DR. JOSEPH ALLEN MOORE MD NPI 1750777959

NPI Details

DR. Joseph Allen Moore, MD is a medical oncology internal medicine in Wichita, KS with 11 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Joseph Allen Moore, MD NPI is 1750777959. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF KANSAS SCHOOL OF MED (KC/WICH/SAL)
Graduation Year:2015

The provider's business location address is:

3243 E MURDOCK ST STE 300
WICHITA, KS
ZIP 67208-006
Phone: (316) 262-4467

The NPI 1750777959 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, granisetron, extended-release, 0.1 mg (HCPCS:J1627)
• Injection, docetaxel, 1 mg (HCPCS:J9171)
• Injection, rituximab-abbs, biosimilar, (truxima), 10 mg (HCPCS:Q5115)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, etoposide, 10 mg (HCPCS:J9181)
• Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg (HCPCS:Q5108)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Unclassified drugs (HCPCS:J3490)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Magnesium level (HCPCS:83735)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Folic acid level, serum (HCPCS:82746)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection of drug or substance into vein (HCPCS:96374)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Ct scan of chest with contrast (HCPCS:71260)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Drawing of blood for a medical problem (HCPCS:99195)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)

The enumeration date for this NPI number is 4/14/2015 and was last updated on 6/1/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: